Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20,045 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of a pro-healing stent in an animal model of early neoatherosclerosis.
Nicol P, Lutter C, Bulin A, Castellanos MI, Lenz T, Hoppmann P, Lahmann AL, Colleran R, Euller K, Steigerwald K, Neubauer S, Rechenmacher F, Ludwig BS, Weinmüller M, Kerch G, Guo L, Cheng Q, Acampado E, Koppara T, Kessler H, Joner M. Nicol P, et al. Among authors: guo l. Sci Rep. 2020 May 19;10(1):8227. doi: 10.1038/s41598-020-64940-2. Sci Rep. 2020. PMID: 32427835 Free PMC article.
Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents.
Mori H, Cheng Q, Lutter C, Smith S, Guo L, Kutyna M, Torii S, Harari E, Acampado E, Joner M, Kolodgie FD, Virmani R, Finn AV. Mori H, et al. Among authors: guo l. JACC Cardiovasc Interv. 2017 Dec 11;10(23):2375-2387. doi: 10.1016/j.jcin.2017.06.059. Epub 2017 Nov 1. JACC Cardiovasc Interv. 2017. PMID: 29102583 Free article.
Comparison of Endothelial Barrier Functional Recovery After Implantation of a Novel Biodegradable-Polymer Sirolimus-Eluting Stent in Comparison to Durable- and Biodegradable-Polymer Everolimus-Eluting Stents.
Sakamoto A, Torii S, Jinnouchi H, Guo L, Cornelissen A, Kuntz S, Cheng Q, Fernandez R, Paek KH, Harris K, Srivastava MC, Kolodgie FD, Virmani R, Finn AV. Sakamoto A, et al. Among authors: guo l. Cardiovasc Revasc Med. 2021 Mar;24:1-10. doi: 10.1016/j.carrev.2020.08.012. Epub 2020 Aug 13. Cardiovasc Revasc Med. 2021. PMID: 32928693
Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: Implications for short-term dual anti-platelet therapy.
Jinnouchi H, Sato Y, Cheng Q, Janifer C, Kutyna M, Cornelissen A, Wijeratne R, Sakamoto A, Guo L, Kolodgie FD, Tunev S, Virmani R, Finn AV. Jinnouchi H, et al. Among authors: guo l. Int J Cardiol. 2021 Mar 15;327:52-57. doi: 10.1016/j.ijcard.2020.11.030. Epub 2020 Nov 23. Int J Cardiol. 2021. PMID: 33242506
Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.
Habib A, Polavarapu R, Karmali V, Guo L, Van Dam R, Cheng Q, Akahori H, Saeed O, Nakano M, Pachura K, Hong CC, Shin E, Kolodgie F, Virmani R, Finn AV. Habib A, et al. Among authors: guo l. Atherosclerosis. 2015 Aug;241(2):692-700. doi: 10.1016/j.atherosclerosis.2015.06.025. Epub 2015 Jun 19. Atherosclerosis. 2015. PMID: 26125411 Free PMC article.
CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.
Guo L, Akahori H, Harari E, Smith SL, Polavarapu R, Karmali V, Otsuka F, Gannon RL, Braumann RE, Dickinson MH, Gupta A, Jenkins AL, Lipinski MJ, Kim J, Chhour P, de Vries PS, Jinnouchi H, Kutys R, Mori H, Kutyna MD, Torii S, Sakamoto A, Choi CU, Cheng Q, Grove ML, Sawan MA, Zhang Y, Cao Y, Kolodgie FD, Cormode DP, Arking DE, Boerwinkle E, Morrison AC, Erdmann J, Sotoodehnia N, Virmani R, Finn AV. Guo L, et al. J Clin Invest. 2018 Mar 1;128(3):1106-1124. doi: 10.1172/JCI93025. Epub 2018 Feb 19. J Clin Invest. 2018. PMID: 29457790 Free PMC article.
Imaging Human Platelet Adhesion and Albumin Retention to Coronary Stents in Real Time.
Jinnouchi H, Kutyna M, Sakamoto A, Torii S, Guo L, Mori H, Cheng Q, Virmani R, Kolodgie FD, Finn AV. Jinnouchi H, et al. Among authors: guo l. Cardiovasc Revasc Med. 2020 Feb;21(2):245-248. doi: 10.1016/j.carrev.2019.09.006. Epub 2019 Sep 12. Cardiovasc Revasc Med. 2020. PMID: 31771813 No abstract available.
Advances in mammalian target of rapamycin kinase inhibitors: application to devices used in the treatment of coronary artery disease.
Jinnouchi H, Guo L, Sakamoto A, Sato Y, Cornelissen A, Kawakami R, Mori M, Torii S, Kuntz S, Harari E, Mori H, Fuller D, Gadhoke N, Fernandez R, Paek KH, Surve D, Romero M, Kolodgie FD, Virmani R, Finn AV. Jinnouchi H, et al. Among authors: guo l. Future Med Chem. 2020 Jun;12(12):1181-1195. doi: 10.4155/fmc-2019-0304. Epub 2020 May 20. Future Med Chem. 2020. PMID: 32431177 Free PMC article. Review.
20,045 results
You have reached the last available page of results. Please see the User Guide for more information.